University of Copenhagen joins European health elite
Copenhagen (Denmark) – Knowledge, growth and visions for future health. These will be the keywords when the University of Copenhagen formally becomes part of the strategic alliance ‘Health Axis Europe’ on Thursday 27 August 2015 at 14.00. The alliance collaborates on sharing resources across Europe and strengthening the competitiveness through healthcare innovation.
The University of Copenhagen will become part of the strategic alliance ‘Health Axis Europe’. The alliance consists of the biomedical clusters Cambridge (UK), Leuven (Belgium), Maastricht (Netherlands) and Heidelberg (Germany) and works to foster innovation in the healthcare sector and generate growth through knowledge and collaboration.
“Like the other Health Axis Europe clusters, Copenhagen represents one of the major biomedical innovation hubs in Europe,” says Christian Tidona, Managing Director of the BioRN Network in Heidelberg. “Building on our recent joint success in the initiation of the EIT Health consortium, I am looking forward to many more pan-European projects that significantly contribute to the advancement of health research and innovation in Europe.”
University of Copenhagen strengthens international profile
Established in 2011, ‘Health Axis Europe’ works to facilitate and coordinate EU-funded research and development collaboration. In addition, the alliance supports the education of talented researchers and works with investments and venture initiatives across Europe.
“I am delighted about this agreement and see great potential in being a partner in such a unique international forum. This collaboration promotes interactions between leading researchers and entrepreneurs exchange ideas and knowledge that will generate new research projects and start-up companies, which will be of great importance for the future healthcare sector. This agreement is a value-creating result of the University of Copenhagen’s internationalisation and focus on establishing relations and networks within healthcare innovation,” says Dean Ulla Wewer.
The alliance is managed and coordinated by the Health Axis Europe Committee, comprised of key individuals from each cluster representing local industry, science, politics, and venture capital. The parties in the alliance are Cambridge Biomedical Campus, the University of Leuven, the BioRN Network in Heidelberg, and the Brightlands Consortium in Maastricht, consisting of the Maastricht University, the Maastricht Health Campus and the Chemelot Campus. The partners agreed on the initiation and coordination of cross-border cooperation in research and development and on the support of start-ups.
For more information, please contact:
Dean Ulla Wewer via Head of Communications, Anéh Christina Hajdu, Phone +45 2122 2692 or at firstname.lastname@example.org
Managing Director Christian Tidona via Head of Public Relations, Eva-Maria Gottmann, Phone + 49-6221-65456 0 or at email@example.com
About BioRN Network e.V.
The BioRN Network in Heidelberg represents the Biotech Cluster Rhine-Neckar (BioRN). It unites renowned research institutions such as the University of Heidelberg, the German Cancer Research Center (DKFZ), the European Molecular Biology Laboratory (EMBL), and large global companies such as Roche, BASF, Merck and AbbVie. Together with more than 80 biotech companies, numerous suppliers and sector-specific service providers, as well as regional associations, local authorities and chambers, the BioRN Network is helping to develop the Rhine-Neckar Metropolitan Region into one of the leading innovation hubs for the life sciences in Europe.